Literature DB >> 12954985

Diversity of core antigen epitopes of hepatitis B virus.

D M Belnap1, N R Watts, J F Conway, N Cheng, S J Stahl, P T Wingfield, A C Steven.   

Abstract

Core antigen (cAg), the viral capsid, is one of the three major clinical antigens of hepatitis B virus. cAg has been described as presenting either one or two conformational epitopes involving the "immunodominant loop." We have investigated cAg antigenicity by cryo-electron microscopy at approximately 11-A resolution of capsids labeled with monoclonal Fabs, combined with molecular modeling, and describe here two conformational epitopes. Both Fabs bind to the dimeric external spikes, and each epitope has contributions from the loops on both subunits, explaining their discontinuous nature: however, their binding aspects and epitopes differ markedly. To date, four cAg epitopes have been characterized: all are distinct. Although only two regions of the capsid surface are accessible to antibodies, local clustering of the limited number of exposed peptide loops generates a potentially extensive set of discontinuous epitopes. This diversity has not been evident from competition experiments because of steric interference effects. These observations suggest an explanation for the distinction between cAg and e-antigen (an unassembled form of capsid protein) and an approach to immunodiagnosis, exploiting the diversity of cAg epitopes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954985      PMCID: PMC196897          DOI: 10.1073/pnas.1834404100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The crystal structure of the human hepatitis B virus capsid.

Authors:  S A Wynne; R A Crowther; A G Leslie
Journal:  Mol Cell       Date:  1999-06       Impact factor: 17.970

3.  Methods for reconstructing density maps of "single" particles from cryoelectron micrographs to subnanometer resolution.

Authors:  J F Conway; A C Steven
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

4.  Low-resolution density maps from atomic models: how stepping "back" can be a step "forward".

Authors:  D M Belnap; A Kumar; J T Folk; T J Smith; T S Baker
Journal:  J Struct Biol       Date:  1999 Apr-May       Impact factor: 2.867

5.  Bsoft: image and molecular processing in electron microscopy.

Authors:  J B Heymann
Journal:  J Struct Biol       Date:  2001 Feb-Mar       Impact factor: 2.867

6.  The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; David M Belnap; Alasdair C Steven; Paul T Wingfield
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

7.  Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.

Authors:  M A Baumeister; A Medina-Selby; D Coit; S Nguyen; C George-Nascimento; A Gyenes; P Valenzuela; G Kuo; D Y Chien
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

8.  Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens.

Authors:  J F Conway; N Cheng; A Zlotnick; S J Stahl; P T Wingfield; D M Belnap; U Kanngiesser; M Noah; A C Steven
Journal:  J Mol Biol       Date:  1998-06-26       Impact factor: 5.469

Review 9.  Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.

Authors:  B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

10.  Tetrairidium, a four-atom cluster, is readily visible as a density label in three-dimensional cryo-EM maps of proteins at 10-25 A resolution.

Authors:  N Cheng; J F Conway; N R Watts; J F Hainfeld; V Joshi; R D Powell; S J Stahl; P E Wingfield; A C Steven
Journal:  J Struct Biol       Date:  1999-09       Impact factor: 2.867

View more
  36 in total

1.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Combinatorial approach to hepadnavirus-like particle vaccine design.

Authors:  Jean-Noel Billaud; Darrell Peterson; Margaret Barr; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Comparative antigenicity and immunogenicity of hepadnavirus core proteins.

Authors:  Jean-Noel Billaud; Darrell Peterson; Florian Schödel; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Interaction of the hepatitis B core antigen and the innate immune system.

Authors:  Byung O Lee; Amy Tucker; Lars Frelin; Matti Sallberg; Joyce Jones; Cory Peters; Janice Hughes; David Whitacre; Bryan Darsow; Darrell L Peterson; David R Milich
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

5.  Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.

Authors:  Jean-Noel Billaud; Darrell Peterson; Byung O Lee; Toshiyuki Maruyama; Antony Chen; Matti Sallberg; Fermin Garduño; Phillip Goldstein; Janice Hughes; Joyce Jones; David Milich
Journal:  Vaccine       Date:  2006-11-17       Impact factor: 3.641

6.  Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.

Authors:  Andreas Walker; Claudia Skamel; Jolanta Vorreiter; Michael Nassal
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

7.  Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.

Authors:  Norman R Watts; Giovanni Cardone; Joe G Vethanayagam; Naiqian Cheng; Catharina Hultgren; Stephen J Stahl; Alasdair C Steven; Matti Sällberg; Paul T Wingfield
Journal:  J Mol Biol       Date:  2008-04-09       Impact factor: 5.469

8.  An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles.

Authors:  Jun Lin; Naiqian Cheng; Marie Chow; David J Filman; Alasdair C Steven; James M Hogle; David M Belnap
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

9.  Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.

Authors:  Weimin Wu; Zhaochun Chen; Naiqian Cheng; Norman R Watts; Stephen J Stahl; Patrizia Farci; Robert H Purcell; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2012-10-16       Impact factor: 2.867

10.  Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids.

Authors:  Birgit Rabe; Mildred Delaleau; Andreas Bischof; Michael Foss; Irina Sominskaya; Paul Pumpens; Christian Cazenave; Michel Castroviejo; Michael Kann
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.